Welcome to the Cellumen Newsroom

Recent Press Releases

Cellumen Partners with Alzheimer's Drug Discovery Foundation to Develop New Assays for Early Treatment of Alzheimer
(30 Sep 2008)
Cellumen announces an agreement with the Alzheimer's Drug Discovery Foundation to apply Cellumen's CSB™ technology to create a cellular model of Alzheimer's disease.

Cellumen Selected as Signature Partner of Drug Safety Executive Council (23 Sep 2008)
Cellumen is one of only eight technology and service providers chosen for Discovery Toxicology.

Cellumen and Mitsubishi Tanabe Pharma Corp. Collaborate in Discovery Toxicology (19 Aug 2008)
Cellumen will collaborate with Mitsubishi Tanabe Pharma, one of the leading pharmaceutical companies in Japan, to develop panels of biomarkers that identify toxicity early in the drug development process.

Cellumen Spins Off Personalized Medicine Unit as Cernostics Pathology, Inc. (16 Jul 2008)
Cernostics Pathology will become the leading provider of digital imaging pathology and tissue-based diagnostic products and services applied to personalized medicine.

Cellumen Collaborates with NCTR of the FDA to Apply Cellular Systems Biology (CSB™) to Predictive Toxicology (30 Jun 2008)
Cellumen uses its proprietary CellCiphr^® toxicity risk assessment technology in collaboration with the National Center for Toxicology Research.

Cellumen Collaborates with Mayo Clinic on Patient Stratification (1 Oct 2007)
Cellumen announces cellular systems biology collaboration with Mayo Clinic in breast cancer patient tissue profiling.